Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the heart outcomes prevention evaluation study

Diabetes Care

Volumn 23, Issue SUPPL. 2, 2000, Pages

  Gerstein, Hertzel C ^a,i,j   Mann, Johannes F E ^e   Pogue, Janice ^a   Dinneen, Sean F ^f   Hallé, Jean Pierre ^b   Hoogwerf, Byron ^g   Joyce, Carol ^c   Rashkow, Andrew ^h   Young, James ^g   Zinman, Bernard ^d   Yusuf, Salim ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e Klinikum Schwabing   (Germany)

^f MAYO CLINIC   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h GRIFFIN HOSPITAL   (United States)

ⁱ NONE   (Canada)

^j HGH McMaster Clinic   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RAMIPRIL;

ADULT; AGED; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OUTCOMES RESEARCH; PREVALENCE; PRIMARY PREVENTION; PROTEINURIA; RISK FACTOR; VASCULAR DISEASE;

AGED; ALBUMINURIA; BODY CONSTITUTION; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INSULIN; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; SMOKING; VASCULAR DISEASES;

EID: 0034029905     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Gerstein HC, Bosch J, Pogue J, Taylor DW, inman B, Yusuf S, HOPE Study Investigators: Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes: the MICRO-HOPE Study. Diabetes Care 19: 1225-1228, 1996
2. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuna as a predictor of vascular disease in non-diabetic subjects: Islington Diabetes Survey. Lancet ii:530-533, 1988
3. Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM: Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the Insulin Resistance Atherosclerosis Study. Diabetes 47:793-800, 1998
4. Dinneen SE Gerstein HC: The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. Arch Int Med 157:1413-1418, 1997
5. Schmitz A, Vaeth M: Microalbuminuria: a major risk factor in type 2 diabetes. A 10-year follow-up study of 503 patients. Diabet Med 5:126-134, 1988
6. Cirillo M, Senigalliesi I, Laurenzi M, Alfieri R, Stamler J, Stamler R, Panarelli W, De Santo NG: Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: the Gubbio Population Study. Arch Intern Med 158:1933-1939, 1998
7. HOPE Study Investigators: The HOPE (Heart Outcomes Prevention Evaluations) Study: the design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. Can J Cardiol 12:127-137, 1996
8. Bruno G, Cavallo-Perin P, Bargero G, Borra M, D'Errico N, Pagano G: Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus. Ann Intern Med 125:653-657, 1996
9. Haffner SM, Gonzales C, Valdez RA, Mykkanen L, Hazuda HP, Mitchell BD, Monterrosa A, Stern MP: Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study. Diabetolgia 36: 1002-1006, 1993
10. Zelmanovitz T, Gross JL, Oliveira JR, Paggi A, Tatsch M, Azevedo MJ: The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care 20:516-519, 1997
11. Jensen JS, Clausen P, Borch-Johnsen K, Feldt-Rasmussen B: Detecting microalbuminuria by urinary albumin/creatinine concentration ratio. Nephrol Dial Transplant 12: 6-9, 1997
12. Chaiken RL, Khawaja R, Bard M, Eckert-Norton M, Banerji MA, Lebovitz HE: Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects. Diabetes Care 20: 709-713, 1997
13. Vestbo E, Damsgaard EM, Froland A, Mogensen CE: Urinary albumin excretion in a population based cohort. Diabet Med 12:488-493, 1995
14. Hofmann W, Guder WG: A diagnostic programme for quantitative analysis of proteinuria. J Clin Chem Clin Biochem 27:589-600, 1989
15. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS: Comparison of diabetes diagnostic categories in the U.S. population according to 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care 20:1859-1862, 1997
16. Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M: Microalbuminuria precedes the development of NIDDM. Diabetes 43:552-557, 1994
17. Coutinho M, Gerstein HC, Wang Y, Yusuf S: The relationship between glucose and incident cardiovascular events: a meta-regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22:233-240, 1999